Evekeo ODT™ (amphetamine sulfate) – Expanded indication, new strength
April 16, 2021 - The FDA approved Arbor Pharmaceuticals’ Evekeo ODT (amphetamine sulfate), for the treatment of attention deficit hyperactivity disorder (ADHD) in pediatric patients 3 to 17 years of age.
Download PDF
